首页> 外国专利> A method for evaluating the effectiveness of treatment of chronic urogenital chlamydiosis sexual partners

A method for evaluating the effectiveness of treatment of chronic urogenital chlamydiosis sexual partners

机译:一种评估慢性泌尿生殖系统衣原体性伴侣治疗效果的方法

摘要

FIELD: medicine, dermatovenerology. SUBSTANCE: the present innovation deals with detecting curability degree against chronic urogenial chlamydiosis in sex couple. At the end of 4th, 8th,12th and 16th wk after therapy finish in case of sex life at applying a condom one should , first, evaluate clinico-laboratory signs in the foci of chronic infectious process and, also, the dynamics of laboratory values which characterize agent's elimination (IgA to C.trachomatis in blood serum and DNA C.trachomatis in cervical tract and urethra). In case of positive results in future (after 16th-17th wk) it is recommended to perform sex life without applying any condom and conduct clinico-laboratory evaluation in both partners at the end of 4th, 8th and 12th wk after condom's removal (at the end of 20th, 24th and 28th wk after therapy finish) and after availability of positive PCR-test (in males' urethra, in females" urethra and/or cervical canal) one should evaluate repeated infection (reinfection) from the partner in case of poorly cured chronic urogenital chlamydiosis, in case of no positive PCR-test in both partners, and negative serological values (IgA) and no clinico-laboratory signs of the focus for chronic and acute infectious process being characteristic for chlamydiosis - one should detect curability degree in sex couple. EFFECT: increased number of preparations to treat chlamydiosis. 5 ex, 6 tbl
机译:领域:医学,皮肤性病学。物质:本发明涉及检测针对性伴侣的慢性泌尿道披衣菌病的治愈程度。如果发生以下情况,在治疗结束后第4 ,第8 ,第12 和第16 使用安全套时的性生活,首先应评估慢性感染过程中的临床实验室体征,还应表征表征消除病原体(血清和DNA沙眼衣原体中的IgA到沙眼衣原体)的实验室值动态。在子宫颈和尿道)。如果将来有积极的结果(第16周 -17 周之后),建议在不使用任何避孕套的情况下进行性生活,并在两个伴侣中进行临床实验室评估取出避孕套后第4 th ,第8 和第12 结束时(第20 结束时) >,治疗结束后每周第24 和第28 ,并且在进行阳性PCR试验后(男性尿道,女性尿道和/或宫颈管)如果慢性泌尿生殖道衣原体病治愈不佳,两个伴侣的PCR检测均不阳性,血清学数值(IgA)阴性且没有慢性病灶的临床实验室迹象,则应评估该伴侣的重复感染(再感染)和衣原体病的急性感染过程是特征性的-应该检测性别夫妇的治愈程度效果:治疗衣原体病的制剂数量增加5 ex,6 tbl

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号